Hb Adana (HBA2 or HBA1: c.179G > A) and alpha thalassemia: Genotype–phenotype correlation

Alpha thalassemia due to nondeletional mutations usually leads to more severe disease than that caused by deletional mutations. Devastating outcomes such as hydrops fetalis can occur with two nondeletional mutations, therefore warranting DNA‐based workup for suspected carriers with subtle hematological abnormalities for family counseling purposes. We describe three cases with hemoglobin (Hb) Adana, a nondeletional alpha chain mutation, compounded with an alpha globin gene deletion resulting in thalassemia intermedia. We review the literature, draw genotype–phenotype correlations from published cases of Hb Adana, and propose that this correlation can be used by clinicians to help direct diagnostic studies and urge hematologists to thoroughly workup high‐risk patients.

[1]  E. Ismail,et al.  Molecular Characterisation of α‐ and β‐Thalassaemia among Indigenous Senoi Orang Asli Communities in Peninsular Malaysia , 2017, Annals of human genetics.

[2]  Jin Ai Mary Anne Tan,et al.  DNA studies are necessary for accurate patient diagnosis in compound heterozygosity for Hb Adana (HBA2:c.179>A) with deletional or nondeletional α-thalassaemia , 2016, Scientific Reports.

[3]  Masomeh Mehrabi,et al.  The Spectrum of α-Thalassemia Mutations in Kermanshah Province, West Iran , 2015, Hemoglobin.

[4]  T. Celkan,et al.  Evaluation of Alpha-Thalassemia Mutations in Cases with Hypochromic Microcytic Anemia: The İstanbul Perspective , 2015, Turkish journal of haematology : official journal of Turkish Society of Haematology.

[5]  T. Gambin,et al.  Alpha-Thalassemia Mutations in Adana Province, Southern Turkey: Genotype-Phenotype Correlation , 2015, Indian Journal of Hematology and Blood Transfusion.

[6]  N. Yaralı,et al.  Homozygosity for HBA1: c.179G > A: Hb Adana in an Infant , 2014, Hemoglobin.

[7]  D. Weatherall,et al.  The α-thalassemias. , 2014, The New England journal of medicine.

[8]  H. Alias,et al.  A Case Series of α-Thalassemia Intermedia Due to Compound Heterozygosity for Hb Adana [HBA2: c179G>A (or HBA1); p.Gly60Asp] With Other α-Thalassemias in Malay Families , 2014, Hemoglobin.

[9]  Faisal Muti Al-hassan,et al.  Molecular Characterization of α- and β-Thalassaemia among Malay Patients , 2014, International journal of molecular sciences.

[10]  O. Ainoon,et al.  Molecular characteristic of alpha thalassaemia among patients diagnosed in UKM Medical Centre. , 2014, The Malaysian journal of pathology.

[11]  Susi Susanah,et al.  Severe α-Thalassemia Intermedia Due to a Compound Heterozygosity for the Highly Unstable Hb Adana (HBA2: c.179G>A) and a Novel Codon 24 (HBA2: c.75T>A) Mutation , 2013, Hemoglobin.

[12]  A. A. Bakar,et al.  A Rare Case of Compound Heterozygous Haemoglobin Q-Thailand and , 2014 .

[13]  I. Setianingsih,et al.  Interaction of Hb Adana (HBA2: c.179G>A) with Deletional and Nondeletional α +-Thalassemia Mutations: Diverse Hematological and Clinical Features , 2013, Hemoglobin.

[14]  J. Borgio,et al.  Spectrum of α-Thalassemia Mutations in Transfusion-Dependent β-Thalassemia Patients from the Eastern Province of Saudi Arabia , 2013, Hemoglobin.

[15]  M. Hamid,et al.  Identification of α-globin chain variants: a report from Iran. , 2012, Archives of Iranian medicine.

[16]  M. Alberry,et al.  Prenatal diagnosis of hb h hydrops fetalis caused by haemoglobin ADANA , 2012, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[17]  E. Vichinsky.  Advances in the treatment of alpha-thalassemia. , 2012, Blood reviews.

[18]  O. Solberg,et al.  E-learning for carers , 2010, Orphanet Journal of Rare Diseases.

[19]  I. Setianingsih,et al.  HYDROPS FETALIS ASSOCIATED WITH HOMOZYGOSITY FOR Hb ADANA [α59(E8)Gly→Asp (α2)] , 2010, Hemoglobin.

[20]  M. Economou,et al.  A case of mild thalassemic syndrome caused by interaction of Hb Adana with an alpha+-thalassemia deletion. , 2010, Journal of pediatric hematology/oncology.

[21]  F. Ozkinay,et al.  A severe alpha thalassemia case compound heterozygous for Hb Adana in alpha1 gene and 20.5 kb double gene deletion. , 2009, Journal of pediatric hematology/oncology.

[22]  H. Najmabadi,et al.  Molecular Characterization of α-Thalassemia in the Dohuk Region of Iraq , 2009, Hemoglobin.

[23]  S. Fucharoen,et al.  Hb H disease: clinical course and disease modifiers. , 2009, Hematology. American Society of Hematology. Education Program.

[24]  E. Vichinsky.  Alpha thalassemia major--new mutations, intrauterine management, and outcomes. , 2009, Hematology. American Society of Hematology. Education Program.

[25]  S. Henderson,et al.  Molecular prenatal diagnosis of Hb H Hydrops Fetalis caused by haemoglobin Adana and the implications to antenatal screening for α‐thalassaemia , 2008, Prenatal diagnosis.

[26]  I. Papassotiriou,et al.  Unstable and Thalassemic α Chain Hemoglobin Variants: A Cause of Hb H Disease and Thalassemia Intermedia , 2008, Hemoglobin.

[27]  I. Papassotiriou,et al.  A Rare Thalassemic Syndrome Caused by Interaction of Hb Adana [α59(E8)Gly→Asp] with an α+-Thalassemia Deletion: Clinical Aspects in Two Cases , 2008, Hemoglobin.

[28]  H. Najmabadi,et al.  Elucidating the spectrum of α-thalassemia mutations in Iran , 2007 .

[29]  M. A. Çürük.  Hb H ( 4 ) Disease in ukurova, Southern Turkey* , 2007 .

[30]  H. Najmabadi,et al.  Elucidating the spectrum of alpha-thalassemia mutations in Iran. , 2007, Haematologica.

[31]  M. A. Çürük.  Hb H (beta4) disease in Cukurova, Southern Turkey. , 2007, Hemoglobin.

[32]  Z. Zubaidah,et al.  Screening of concurrent alpha-thalassaemia 1 in beta-thalassaemia carriers. , 2006, The Medical journal of Malaysia.

[33]  D. Chui.  α‐Thalassemia: Hb H Disease and Hb Barts Hydrops Fetalis , 2005, Annals of the New York Academy of Sciences.

[34]  V. Chan,et al.  Hemoglobin H disease: not necessarily a benign disorder. , 2003, Blood.

[35]  I. Setianingsih,et al.  Alpha thalassaemia in Indonesia: phenotypes and molecular defects. , 2003, Advances in experimental medicine and biology.

[36]  D. Chui,et al.  Detection of severe nondeletional alpha-thalassemia mutations using a single-tube multiplex ARMS assay. , 2001, Genetic testing.

[37]  V. Chan,et al.  Genetic and clinical features of hemoglobin H disease in Chinese patients. , 2000, The New England journal of medicine.

[38]  I. Papassotiriou,et al.  Interaction of an α+-Thalassemia Deletion with Either a Highly Unstable α-Globin Variant (α2, Codon 59, GGC→GAC) or a Nondeletional α-Thalassemia Mutation (AATAA→AATAAG): Comparison of Phenotypes Illustrating “Dominant” α-Thalassemia , 1999 .

[39]  I. Papassotiriou,et al.  Interaction of an alpha(+)-thalassemia deletion with either a highly unstable alpha-globin variant (alpha2, codon 59, GGC-->GAC) or a nondeletional alpha-thalassemia mutation (AATAAA-->AATAAG): comparison of phenotypes illustrating "dominant" alpha-thalassemia. , 1999, Hemoglobin.

[40]  D. Chui,et al.  Hydrops Fetalis Caused by α-Thalassemia: An Emerging Health Care Problem , 1998 .

[41]  D. Chui,et al.  Hydrops fetalis caused by alpha-thalassemia: an emerging health care problem. , 1998, Blood.

[42]  T. Huisman,et al.  Hb adana or α259(E8)Gly→Aspβ2, A severely unstable α1‐globin variant, observed in combination with the ‐(α)20.5 KB α‐thal‐1 deletion in two Turkish patients , 1993 .

[43]  D. Williamson.  The unstable haemoglobins. , 1993, Blood reviews.

[44]  T. Huisman,et al.  Hb Adana or alpha 2(59)(E8)Gly-->Asp beta 2, a severely unstable alpha 1-globin variant, observed in combination with the -(alpha)20.5 Kb alpha-thal-1 deletion in two Turkish patients. , 1993, American journal of hematology.

[45]  A. Hill,et al.  Different hematologic phenotypes are associated with the leftward (-alpha 4.2) and rightward (-alpha 3.7) alpha+-thalassemia deletions. , 1987, The Journal of clinical investigation.